PACK Pharmaceuticals Recalls Timolol Maleate Eye Drops Due to Container Defects
PACK Pharmaceuticals is recalling specific lots of Timolol Maleate eye drops because stability samples showed white solid residue on the exterior of the bottles.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The FDA classified this as a Class III recall, which indicates the product is not likely to cause adverse health consequences. The defect is cosmetic (exterior residue) with no reported injuries or illnesses.
Plain-English summary
PACK Pharmaceuticals, LLC is voluntarily recalling 3,415 bottles of Timolol Maleate Sterile Ophthalmic Solution, USP 0.25%, 5mL (NDC 16571-140-50). The affected products are packaged in Low Density Polyethylene (LDPE) Blow Fill Seal containers with dropper tips and are individually packaged in fiberboard cartons.
The recall was initiated because stability samples of the products were noted to have white solid product residue on the exterior of the bottles. This residue was identified as dried active ingredients along with the preservative. The affected lots are NW3061 and NW3062, with an expiration date of 05/15.
The products were distributed nationwide and in Puerto Rico. Consumers should check their eye drop bottles for the specific lot numbers and expiration date listed above. If the product matches the recalled description, consumers should stop using it and contact their healthcare provider or the recalling firm for further instructions.
The recalled product
- Product
- Timolol Maleate Sterile Ophthalmic Solution, USP 0.25%, 5mL, (NDC 16571-140-50). The products are packaged in Low Density Polyethylene (LDPE) Blow Fill Seal containers equipped with a dropper tip. The filled bottles are individually packaged into fiberboard cartons.
- Manufacturer
- PACK Pharmaceuticals, LLC
- Category
- Drug — Ophthalmic Solution
- Affected units
- 3,415
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: NW3061
- NW3062. Exp. 05/15.
Distribution
Part of a larger recall action
This product is one of 6 recalled by PACK Pharmaceuticals, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 6 products in this recall →Related recalls
Same manufacturer · PACK Pharmaceuticals, LLC
See all →- LowTimolol Maleate Eye Drops Recalled for Exterior Bottle Residue
FDA (Drugs) · 2014-02-12
- LowTimolol Maleate Eye Drops Recalled Due to Exterior Residue
FDA (Drugs) · 2014-02-12
- LowPACK Pharmaceuticals Recalls Timolol Maleate Eye Drops Due to Exterior Residue
FDA (Drugs) · 2014-02-12
- LowPACK Pharmaceuticals Recalls Ofloxacin Ophthalmic Solution Due to Container Defects
FDA (Drugs) · 2014-02-12
- LowPACK Pharmaceuticals Recalls Ofloxacin Ophthalmic Solution Due to Container Defects
FDA (Drugs) · 2014-02-12
Same hazard · packaging defect
See all →- HighMD Wipe Outz Numbing Tattoo Wipes Recalled for Child Poisoning Risk
CPSC · 2026-08-27
- SevereDermalon Sutures Recalled for Potential Sterile Barrier Packaging Defects
FDA (Devices) · 2026-08-19
- HighV-Loc 90 Absorbable Wound Closure Devices Recalled for Packaging Defects
FDA (Devices) · 2026-08-19
- HighV-Loc 180 Absorbable Wound Closure Device Recalled for Packaging Defects
FDA (Devices) · 2026-08-19
- HighBiopsy Forceps Recall: Sterile Packaging Breach Risk
FDA (Devices) · 2026-08-12